NCT00302822View on ClinicalTrials.gov

Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130)

PHASE3CompletedINTERVENTIONAL

Enrollment

195

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

HIV InfectionsAIDS

Interventions

DRUG

enfuvirtide

from week 0 to 24

DRUG

emtricitabine/tenofovir

1 pill/day

DRUG

lopinavir or efavirenz

investigator choice

Trial Locations (1)

75018

Service des Maladies Infectieuses A Hôpital Bichat-Claude Bernard, Paris

Sponsors

Collaborators (1)

Gilead Sciences

All Listed Sponsors

collaborator

Hoffmann-La Roche

INDUSTRY

collaborator

Gilead Sciences

INDUSTRY

lead

French National Agency for Research on AIDS and Viral Hepatitis

OTHER_GOV